Pharma CEOs didn’t show up for a congressional scolding, so progressives shadowboxed instead
Progressive lawmakers invited six drug industry CEOs to Capitol Hill to prod them about high drug prices. None showed up — so the Democrats scolded their empty chairs instead.
WASHINGTON — “Is Heather Bresch here?”
The mock roll call from Rep. Mark Pocan (D-Wis.) was orchestrated largely in jest. In front of him stood six empty shares and an empty table, topped by six nameplates without faces to match. Bresch, the CEO of the generic drug maker Mylan, was not there. Nor were the other five pharmaceutical industry executives who progressive lawmakers had “invited” to testify, and whose names Pocan called
